BRAND_ANALYSIS#GLAXOSMITHKLINEHEALTH & PHARMA#4 OF 26 IN HEALTH & PHARMAINTERESTING
GlaxoSmithKline
· Public · Updated 22 Nov 2026 07:19 UTC
#66 of 1208 overall by tension · #4 of 26 in Health & Pharma
26Interesting
The Silent Giant
Analysis
C=35, B=61, down 5.9% — GSK is a pharmaceutical giant in the middle of a prolonged identity crisis, having spun off Haleon and rebranded while litigation risk from Zantac haunts the balance sheet. The lowest C score in this batch for a reason: nobody has a relationship with GSK, they just occasionally take its drugs. T=26 is generous.